Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral

Sudha S Shankar1, Michael P Dubé

  • 1Department of Medicine and Divisions of Endocrinology, Indiana University School of Medicine, Indianapolis, IN, USA.

Insights

Human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs) may cause endothelial dysfunction, a key step in atherosclerosis. This dysfunction is linked to lipid and glucose metabolism changes, impacting cardiovascular health in HIV patients.

Area of Science:

  • Cardiovascular Science
  • Infectious Disease Research
  • Pharmacology

Background:

  • Endothelial dysfunction is a primary event in atherogenesis, contributing to atherosclerosis progression and clinical outcomes.
  • Human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) use is linked to increased cardiovascular events and risk factors like dyslipidemia, insulin resistance, and endothelial dysfunction.
  • Endothelial dysfunction in HIV patients may stem from the infection itself or antiretroviral treatment side effects.

Purpose of the Study:

  • To investigate the role of HIV-1 protease inhibitors (PIs) in causing endothelial dysfunction.
  • To explore the mechanisms by which PIs affect lipid and glucose metabolism, contributing to endothelial dysfunction.
  • To assess the contribution of metabolic and body shape changes associated with HIV treatment-related lipodystrophy to endothelial dysfunction.

Main Methods:

  • Review of available evidence on PI effects on cardiovascular risk factors.
  • Analysis of studies examining endothelial function in healthy subjects treated with specific PIs (e.g., indinavir).
  • Investigation into the physiological mechanisms underlying PI-induced endothelial dysfunction.

Main Results:

  • Evidence suggests PIs can induce endothelial dysfunction through impacts on lipid and glucose metabolism.
  • Studies confirm reduced endothelial nitric oxide production in indinavir-associated endothelial dysfunction.
  • Metabolic alterations and lipodystrophy associated with HIV treatment may contribute to endothelial dysfunction.

Conclusions:

  • HIV-1 PIs are implicated in causing endothelial dysfunction, a critical factor in atherosclerosis development.
  • Further research is required to elucidate the mechanisms and identify effective interventions for endothelial dysfunction in HIV-infected individuals.
  • Understanding the comparative effects of different antiretroviral agents on endothelial function is crucial for managing cardiovascular risk in this population.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...